No Data
No Data
Maxim Group Maintains Fennec Pharmaceuticals(FENC.US) With Buy Rating, Maintains Target Price $15
H.C. Wainwright Maintains Fennec Pharmaceuticals(FENC.US) With Buy Rating, Maintains Target Price $13
Fennec Pharmaceuticals: Strategic Market Expansion and Financial Performance Justify Buy Rating
Express News | HC Wainwright & Co. Reiterates Buy on Fennec Pharmaceuticals, Maintains $13 Price Target
Fennec Pharmaceuticals Analyst Ratings
Fennec Pharmaceuticals | 8-K: FENNEC PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL-YEAR 2024 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE